Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Arcus Biosciences, Inc. Common Stock
(NY:
RCUS
)
30.34
+0.82 (+2.78%)
Official Closing Price
Updated: 7:00 PM EDT, Aug 21, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Arcus Biosciences, Inc. Common Stock
< Previous
1
2
3
4
5
6
7
8
9
...
12
13
Next >
Recap: Arcus Biosciences Q4 Earnings
↗
February 21, 2024
Via
Benzinga
Arcus Biosciences Reports Fourth-Quarter and Full-Year 2023 Financial Results and Provides a Pipeline Update
February 21, 2024
From
Arcus Biosciences
Via
Business Wire
Earnings Scheduled For February 21, 2024
↗
February 21, 2024
Companies Reporting Before The Bell • Gatos Silver (NYSE:GATO) is estimated to report quarterly earnings at $0.09 per share on revenue of $83.00 million.
Via
Benzinga
Preview: Arcus Biosciences's Earnings
↗
February 20, 2024
Via
Benzinga
Arcus Biosciences Announces New Employment Inducement Grants
February 09, 2024
From
Arcus Biosciences
Via
Business Wire
Key Takeaways From Arcus Biosciences Analyst Ratings
↗
January 30, 2024
Via
Benzinga
What 9 Analyst Ratings Have To Say About Arcus Biosciences
↗
November 08, 2023
Via
Benzinga
Arcus Biosciences: Q3 Earnings Insights
↗
November 07, 2023
Via
Benzinga
Expert Ratings for Arcus Biosciences
↗
October 03, 2023
Via
Benzinga
Arcus Biosciences to Host Conference Call to Discuss Fourth-Quarter and Full-Year 2023 Financial Results and Pipeline Updates
February 07, 2024
From
Arcus Biosciences
Via
Business Wire
$320M Bet On This Healthcare Stock? Check Out These 3 Stocks Insiders Are Buying
↗
February 01, 2024
Although U.S. stocks closed lower on Wednesday, there were a few notable insider trades.
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
↗
January 30, 2024
We're starting off trading on Tuesday with a look into the biggest pre-market stock movers traders need to keep an eye on today!
Via
InvestorPlace
Pharma Giant Gilead Raises Stake In Cancer-Focused Arcus Biosciences, Stock Soars
↗
January 30, 2024
Arcus Biosciences sees a 17.1% surge as Gilead Sciences amends collaboration, investing $320M at $21.00/share. Accelerate joint programs in cancer therapy.
Via
Benzinga
Gilead and Arcus Announce Amended Collaboration and Equity Investment
January 29, 2024
From
Arcus Biosciences
Via
Business Wire
Arcus Biosciences Announces New Employment Inducement Grants
January 26, 2024
From
Arcus Biosciences
Via
Business Wire
Data from a Phase 1b Study of Quemliclustat-Based Regimens Showed Promising Overall Survival in Treatment-Naïve Metastatic Pancreatic Cancer
January 16, 2024
From
Arcus Biosciences
Via
Business Wire
Arcus Biosciences Announces New Employment Inducement Grants
December 11, 2023
From
Arcus Biosciences
Via
Business Wire
Exelixis and Arcus Biosciences Announce Clinical Trial Collaboration to Evaluate Zanzalintinib in Combination with AB521 in Patients with Advanced Renal Cell Carcinoma
December 04, 2023
From
Arcus Biosciences
Via
Business Wire
Arcus Biosciences Announces New Employment Inducement Grants
November 27, 2023
From
Arcus Biosciences
Via
Business Wire
From laggards to leaders: Small caps on the rise
November 27, 2023
Despite large-cap dominance, signs suggest a shift to small-cap leadership. Valuations, positive Q3 results, and historical patterns point to potential gains.
Via
MarketBeat
Arcus Biosciences to Participate in the 6th Annual Evercore ISI HealthCONx Conference
November 14, 2023
From
Arcus Biosciences
Via
Business Wire
Arcus Biosciences Announces New Employment Inducement Grants
November 13, 2023
From
Arcus Biosciences
Via
Business Wire
Arcus Biosciences Reports Third Quarter 2023 Financial Results and Provides a Pipeline Update
November 07, 2023
From
Arcus Biosciences
Via
Business Wire
Positive News For Gastric Cancers - Gilead/Arcus Biosciences' Combination Cancer Therapy Shows Encouraging Clinical Activity
↗
November 07, 2023
Gilead Sciences Inc (NASDAQ: GILD) and Arcus Biosciences Inc (NYSE: RCUS) announced that domvanalimab plus zimberelimab and chemotherapy showed encouraging overall response rate (ORR) and six-month...
Via
Benzinga
Gilead and Arcus Announce New Data Showing Encouraging Clinical Activity of Anti-TIGIT Domvanalimab-Containing Regimen as First-line Treatment for Upper GI Cancers
November 06, 2023
From
Gilead Sciences, Inc.
Via
Business Wire
Earnings Scheduled For November 7, 2023
↗
November 07, 2023
Companies Reporting Before The Bell • CorEnergy Infr Tr (NYSE:CORR) is estimated to report earnings for its third quarter.
Via
Benzinga
Arcus Biosciences Announces New Employment Inducement Grants
October 24, 2023
From
Arcus Biosciences
Via
Business Wire
Arcus Biosciences to Present Data from Ongoing EDGE-Gastric Study at ASCO Plenary and to Report Third-Quarter Financial Results on November 7
October 17, 2023
From
Arcus Biosciences
Via
Business Wire
Arcus Biosciences Announces New Employment Inducement Grants
October 10, 2023
From
Arcus Biosciences
Via
Business Wire
Stocks That Hit 52-Week Lows On Thursday
↗
October 05, 2023
On Thursday, 369 companies hit new 52-week lows.
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
...
12
13
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
